2015
DOI: 10.1016/j.ejwf.2014.10.002
|View full text |Cite
|
Sign up to set email alerts
|

Multidisciplinary management of cleidocranial dysplasia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
6
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(7 citation statements)
references
References 16 publications
1
6
0
Order By: Relevance
“…Therefore, the relative or absolute activity of the temporalis muscle can accelerate the occurrence of CPH. Importantly, related literature and our clinical data show that Shprintzen-Goldberg syndrome is associated with the SKI gene and the FBN1 gene, whereas Loeys-Dietz syndrome with mutations in the TGFB gene, cleidocranial dysplasia syndrome with mutations in the RUNX2 gene (Chalala et al, 2015;Tang et al, 2007), and Munchmeyer's disease with mutations in SMAD 2/3 signaling (Bhansali et al, 2021;de Ruiter et al, 2021;Duan et al, 2010;Eekhoff et al, 2018;Okuno et al, 2017;Towler et al, 2020).…”
Section: Discussionsupporting
confidence: 52%
See 1 more Smart Citation
“…Therefore, the relative or absolute activity of the temporalis muscle can accelerate the occurrence of CPH. Importantly, related literature and our clinical data show that Shprintzen-Goldberg syndrome is associated with the SKI gene and the FBN1 gene, whereas Loeys-Dietz syndrome with mutations in the TGFB gene, cleidocranial dysplasia syndrome with mutations in the RUNX2 gene (Chalala et al, 2015;Tang et al, 2007), and Munchmeyer's disease with mutations in SMAD 2/3 signaling (Bhansali et al, 2021;de Ruiter et al, 2021;Duan et al, 2010;Eekhoff et al, 2018;Okuno et al, 2017;Towler et al, 2020).…”
Section: Discussionsupporting
confidence: 52%
“…Cleidocranial dysplasia syndrome (OMIM 119600) is mainly an autosomal‐dominant disease associated with mutations in the RUNX2 gene, which plays an important role in regulating bone metabolism (Jaruga et al, 2016). Cleidocranial dysplasia syndrome is characterized by hypoplasia or complete absence or reduction in the size of the clavicle, zygomatic arch hypoplasia, micromaxillary deformity, maxillary hypoplasia leading to impaired eruption of permanent teeth (often with multiple teeth), and narrowing of the ascending branches of the mandible (Chalala et al, 2015). Chalala et al (2015) reported an 18‐year‐old female patient with cleidocranial dysplasia syndrome who had an unusually elongated and pointed mandibular coronoid process with a distally curved upward‐backward‐pointing coronoid process and no abnormal mouth opening.…”
Section: Resultsmentioning
confidence: 99%
“…3,38 CCD complications do not present a curative therapy; however, some of the disease conditions can be corrected through multidisciplinary treatment aimed at improving the health, esthetics, and quality of life of patients. 39 Dental complications are usually the main intervened sign, and treatment generally involves exodontic and orthodontic procedures; however, the management of complications is challenging and in the long term that requires careful planning. 3,13 On the other hand, some other surgical procedures to correct cranial bone insufficiency have been performed.…”
Section: Discussionmentioning
confidence: 99%
“…Chromosome 6p21 is responsible for the morphogenesis of the skeleton and also in the differentiation of the specific cells as osteoblasts [14][15][16]. RUNX2 is crucial for the proliferation of specific cells specialized for the synthetization of bone and tooth and also the proliferation of osteoblasts [17][18][19][20]. Runt-domain mutations are related to important dental anomalies such as supernumerary teeth, eruption alteration, etc.…”
Section: Introductionmentioning
confidence: 99%